Reducing and managing chronic obstructive pulmonary disease exacerbations with tiotropium + olodaterol.
Conclusions: The early stages of COPD may represent a "window of therapeutic opportunity", when initiation of tiotropium and olodaterol dual bronchodilator therapy may improve lung function and quality of life and reduce exacerbations in patients with COPD.
PMID: 33095662 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Chronic Obstructive Pulmonary | Corticosteroid Therapy | Research | Spiriva | Study | Tiotropium